Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/10/1991 | CA2067181A1 Indole derivatives, their preparation and use |
04/10/1991 | CA2027097A1 Chroman derivatives |
04/09/1991 | US5006655 Process for the preparation of tetrahydrofolates |
04/09/1991 | US5006649 3-propenylcephem derivative |
04/09/1991 | US5006648 Process for preparing partial polyol fatty acid esters |
04/09/1991 | US5006647 Antitumor agents |
04/09/1991 | US5006595 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
04/09/1991 | US5006570 Dihydrobenzofuran- and chroman-carboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics |
04/09/1991 | US5006561 Indane sulfonamide anti-arrhythmic agents and use |
04/09/1991 | US5006560 Use of GABA-B selective agonists as anti-tussive agents |
04/09/1991 | US5006559 Preventing the aspiration of gastric contents on administering anesthesia solution |
04/09/1991 | US5006555 Antiinflammatory, antithrombin, respiratory system disorder treatment |
04/09/1991 | US5006551 Composition for destroying malignant tumors |
04/09/1991 | US5006550 Chroman esters of phenols and benzoic acids having retinoid-like activity |
04/09/1991 | US5006549 Antiinflammatory agents |
04/09/1991 | US5006548 Hyaluronidase inhibitors, antiallergens, immunomodulators |
04/09/1991 | US5006547 Tenidap as an inhibitor of the release of elastase by neutrophils |
04/09/1991 | US5006546 Imidazole derivatives |
04/09/1991 | US5006545 Veterinary compositions against endoparasites containing cypermethrin and albendazole |
04/09/1991 | US5006544 5-hydroxytryptamine antagonist for psychological and gastrointestinal disorders; anxiolytic agents |
04/09/1991 | US5006543 Diphenylethane derivatives |
04/09/1991 | US5006540 Substituted 3-aminosydnonimines, processes for their preparation and their use |
04/09/1991 | US5006539 Thromborane inhibitor |
04/09/1991 | US5006536 Thienobenzoxepins and analgesic compositions thereof |
04/09/1991 | US5006535 Substituted heterocylic 4-aminoquinoline derivatives as gastric acid secretion inhibitors |
04/09/1991 | US5006533 Neuroleptic agents, side effect reduction |
04/09/1991 | US5006531 5,6-dihydro(1H-indolo(3,2-C)quinoline-6,4'-piperidines) and related compounds which are useful for treating pain, psychosis or convulsions |
04/09/1991 | US5006530 Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases |
04/09/1991 | US5006526 Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis |
04/09/1991 | US5006522 Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds |
04/09/1991 | US5006518 Hormone inhibitors for inducing abortions; nontoxic |
04/09/1991 | US5006517 Administering 3-oxo or hydroxy substituted 5-beta-androstan-17-one |
04/09/1991 | US5006515 Immunology disorders, antitumor agent |
04/09/1991 | US5006513 Fungicides, synergistic, itraconazole |
04/09/1991 | US5006360 Liquid and solid polyol fatty acid polyesters with network of polysaccharide fibrils, microfibrils |
04/09/1991 | US5006344 Fosinopril tablet formulations |
04/09/1991 | US5006343 Liposomes, alveolar surfactant protein |
04/09/1991 | US5006342 Resilient transdermal drug delivery device |
04/09/1991 | US5006330 Evaluative means for detecting inflammatory reactivity |
04/09/1991 | US5006259 Puriflying blood using a tetrafluoroethylene copolymer; immunology |
04/09/1991 | US5005588 Method for increasing tumor sensitivity to chemotherapy |
04/09/1991 | CA1282786C Glucose tolerance factor and method of making same |
04/09/1991 | CA1282784C Decahydroquinolein derivatives, process for their preparation, intermediates, use as medicaments and compositions comprising the same |
04/09/1991 | CA1282783C Substituted dihydroimidazo ¬1,2-a| quinoxalines |
04/09/1991 | CA1282782C Guanidine derivatives |
04/09/1991 | CA1282781C 5-[(3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo [c,f] [1,2] thiazepin-11-yl) amino] pentanoic acid, a new tricyclic derivative; process for preparing the same |
04/09/1991 | CA1282780C Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
04/09/1991 | CA1282779C Polysaccharide ron substance, production of the same and use of the same |
04/09/1991 | CA1282727C Chemorepellant compound |
04/09/1991 | CA1282709C Composition for oral hygiene |
04/09/1991 | CA1282707C Sprayable composition to prevent smoking |
04/09/1991 | CA1282704C Ocular antihypertensive composition for topical use |
04/09/1991 | CA1282703C Stable injectable antiemetic compositions |
04/09/1991 | CA1282702C Regimen for treating osteoporosis |
04/09/1991 | CA1282695C Methods and materials for treatment of rheumatoid arthritis |
04/08/1991 | CA2027093A1 Compounds |
04/08/1991 | CA2027074A1 6-0-methylerythromycin a oxime derivatives |
04/07/1991 | CA2027052A1 Therapeutic nucleosides |
04/07/1991 | CA2026972A1 1,4-dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents |
04/06/1991 | WO1991006007A1 Diagnostic kit and diagnostic method utilizing carbohydrate receptors |
04/06/1991 | WO1991004667A1 Use of liposomes as carriers for metalloporphyrins |
04/06/1991 | CA2067734A1 Diagnostic kit and diagnostic method utilizing carbohydrate receptors |
04/06/1991 | CA2042576A1 Use of liposomes as carriers for metalloporphyrins |
04/06/1991 | CA2026856A1 3-substituted-1,4-benzodiazepines useful as oxytocin |
04/06/1991 | CA2026786A1 Compounds |
04/05/1991 | WO1991004982A1 Further antiviral pyrimidine nucleosides |
04/05/1991 | CA2067094A1 Further antiviral pyrimidine nucleosides |
04/05/1991 | CA2026713A1 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
04/05/1991 | CA2026700A1 Substituted 1,3,4-thiadiazolinones, processes for their preparation, and their use for combating endoparasites |
04/04/1991 | WO1991004974A1 2-bicyclo-benzimidazoles, process for their production and drugs containing said compounds |
04/04/1991 | WO1991004261A1 5'-alkylphosphonylnucleosides as antivirals |
04/04/1991 | WO1991004258A1 Inositol derivative and production thereof |
04/04/1991 | WO1991004246A1 Method for preparing amino acid derivatives and therapeutical applications of same |
04/04/1991 | WO1991004039A1 Erection-inducing methods and compositions |
04/04/1991 | WO1991004037A1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
04/04/1991 | WO1991004034A1 Topical preparation for treatment of aphthous ulcers and other lesions |
04/04/1991 | WO1991004033A1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
04/04/1991 | WO1991004032A1 Methods of treating neurodegenerative conditions |
04/04/1991 | WO1991004030A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
04/04/1991 | WO1991004028A1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
04/04/1991 | WO1991004027A1 New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
04/04/1991 | WO1991004024A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
04/04/1991 | WO1991004023A1 Isolating aminoarginine and use to block nitric oxide formation in body |
04/04/1991 | WO1991004021A1 Medicaments for the treatment of toxoplasmosis |
04/04/1991 | WO1991002553A3 Transdermal nitroglycerin patch with penetration enhancers |
04/04/1991 | WO1991002529A3 Product and method for killing abnormal vertebrate cells |
04/04/1991 | WO1991000289A3 Targeted liposomes and methods for liposome-protein coupling |
04/04/1991 | WO1990014067A3 Methods for treating anxiety with sigma receptor ligands |
04/04/1991 | DE3931693A1 Sexualtonikum fuer maenner Sexualtonikum for maenner |
04/04/1991 | CA2066716A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
04/04/1991 | CA2066690A1 2-bicyclobenzimidazoles, processes for their preparation and medicaments containing these compounds |
04/04/1991 | CA2026730A1 Therapeutic nucleosides |
04/04/1991 | CA2026707A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same |
04/04/1991 | CA2026680A1 Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity |
04/04/1991 | CA2012101A1 Antiviral medicinal composition |
04/03/1991 | WO1991004751A1 Inhibitor of absorption of digestion product of food and drink |
04/03/1991 | WO1991004737A1 Osteogenesis promoter |
04/03/1991 | EP0420806A1 Phosphonic acids, process for preparation and use as an active pharmaceutical composition |
04/03/1991 | EP0420805A2 Anthelmintic compounds |
04/03/1991 | EP0420804A2 Anthelmintic compounds |